Sichenzia Ross Friedman Ference LLP Acted as Lead Investor Counsel on VBI Vaccines’ $5.25 million private placement
NEW YORK, August 1, 2014 (GLOBE NEWSWIRE) – New York – based securities law firm, Sichenzia Ross Friedman Ference LLP announces that it represented the lead investor in a $5.25 million private placement conducted by VBI Vaccines Inc. (NASDAQ: VBIV), formerly Paulson Capital (Delaware) Corp. The offering, which originally closed into escrow on July 25, 2013, consisted of the sale of one unit of VBI’s securities, made up of shares of Common Stock, Series A Preferred Stock and two class of warrants exercisable into shares of VBI’s Series B Preferred Stock. The release of the funds and securities in escrow was subject to certain conditions precedent which was satisfied on July 25, 2014, at which time the funds and securities were released.
VBI Vaccines, Inc. is a biopharmaceutical company developing novel technologies that seek to expand vaccine protection in large underserved markets. The Sichenzia Ross Friedman Ference LLP team was led by partner Harvey Kesner and associate Tara Guarneri-Ferrara.
Media Contact
pr@srf.law
212-930-9700
- Sichenzia Ross Ference Carmel LLP 代表 WallachBeth Capital LLC 和 Revere Securities LLC 参与 Trident Digital Tech Holdings Ltd 的 900 万美元首次公开发行。 - September 11, 2024
- Sichenzia Ross Ference Carmel LLP 代表 EF Hutton 参与 Solidion Technology, Inc. 400 万美元的私募交易。 - September 9, 2024
- Sichenzia Ross Ference Carmel LLP 代表 Joseph Gunnar & Co, LLC 参与 Eastside Distilling 的 40 万美元注册直接发行 - September 6, 2024